Biocon Q2 Results
- BSE: 532523
- NSE: BIOCON
- ISIN: INE376G01013
- Sector: Biotechnology & Drugs
BSE
336.35
5.15 (1.55%)
5.15 (1.55%)Volume46.91 K
Updated: Mon 25 Nov, 2024 | 15:29:37
NSE
336.354.85 (1.46%)
4.85 (1.46%)Volume1.45 M
Updated: Mon 25 Nov, 2024 | 15:44:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹3,590.40 Cr.(4.59%)
- Operating Profit₹291.50 Cr.(18.02%)
- Profit After Tax₹-16.00 Cr.(NA%)
- Operating Margin8.12%(-14.38%)
Note: Comparison is on YoY basis
Quarterly - Biocon Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3,590.40 | 3,422.60 | -% | 3,462.30 | -% |
| Selling/ General/ Admin Expenses Total | 789.60 | 579.30 | -% | 622.40 | -% |
| Depreciation/ Amortization | 419.90 | 358.00 | -% | 389.30 | -% |
| Other Operating Expenses Total | 932.80 | 919.30 | -% | 971.30 | -% |
| Total Operating Expense | 3,298.90 | 3,066.20 | -% | 3,134.00 | -% |
| Operating Income | 291.50 | 356.40 | -% | 328.30 | -% |
| Net Income Before Taxes | 98.40 | 183.70 | -% | 214.30 | -% |
| Net Income | -16.00 | 101.40 | -% | 125.60 | -% |
| Diluted Normalized EPS | -0.27 | 0.85 | -% | 1.21 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST